NERV Earnings Minerva Neurosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -2.86 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -34.67 | 2026-03-11 | 10-K |
| Q3 2025 | 2025-09-30 | -1.29 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.93 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.50 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | 0.19 | 2026-03-11 | 10-K |
| Q3 2025 | 2024-09-30 | 0.75 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.22 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.13 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -4.61 | 2025-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -3.41 | 2024-11-05 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.43 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.31 | 2024-05-01 | 10-Q |
| FY 2023 | 2022-12-31 | -6.01 | 2024-02-22 | 10-K |
| Q3 2023 | 2022-09-30 | -4.75 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.46 | 2023-08-01 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.83 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -9.35 | 2023-03-08 | 10-K |
| Q3 2022 | 2021-09-30 | -5.36 | 2022-11-09 | 10-Q |
| Q2 2021 | 2021-06-30 | -0.45 | 2021-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.